General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:        
Net loss $ (46,811) $ (17,915) $ (26,979) $ (6,210)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation and amortization 176 93 151 57
Intangible asset impairment charges   500 500 500
Amortization of debt issuance costs and discount 3,740 1,271 3,604  
Costs of warrants issued at IPO 5,790      
Write-off of debt discounts and issuance costs at IPO 10,132      
Change in fair value of warrant liability (7,114) (117) (950)  
Provision for doubtful accounts 69      
Stock issued to dissenting shareholder   159 159  
Stock-based compensation expense 13,611 1,588 1,730 127
Changes in assets and liabilities:        
Accounts receivable (5,315) (5,523) 1,257 (2,770)
Expenditures billable to clients (1,783) (733) (2,164) 1,983
Prepaid expenses and other current assets (1,641) (174) (305) 506
Accounts payable 3,519 (10,208)    
Accounts media payments 2,597 4,522 (9,188) 8,480
Other Accrued liabilities 651 523 8,441 500
Customer advances 2,009 4,559 (3,005) (771)
Other liabilities     (6) 1
Net cash (used in) provided by operating activities (20,370) (21,455) (26,755) 2,403
Cash flows from investing activities:        
Purchases of marketable securities (39,850)      
Capital expenditures (16) (20) (37) (22)
Software development expenditures       (472)
Additions to intangibles assets (30)      
Deposits for operating leases (774)      
Other     (100)  
Net cash used in investing activities (40,670) (20) (137) (494)
Cash flows from financing activities:        
Net proceeds from public offering 32,580      
Proceeds from exercise of Primary Warrant 29,263      
Proceeds from the exercise of stock options 5 72 77  
Debt issuance costs (68) (168) (168)  
Deferred offering costs     (136)  
Repurchase of Common Stock (56)      
Net cash provided by (used in) financing activities 69,724 9,904 19,773 (1,459)
(Decrease) increase in cash 8,684 (11,571) (7,119) 450
Cash and cash equivalents, beginning of year 12,078 19,197 19,197 18,747
Cash and cash equivalents, end of year 20,762 7,626 12,078 19,197
Cash paid during the periods for:        
Interest 0 0 0 0
Income taxes     13 6
Non-cash investing and financing activities:        
Conversion of convertible notes payable, including accrued interest, to common stock 28,782      
Conversion of redeemable convertible preferred stock to common stock 27,266      
Unpaid deferred IPO cost     316  
Bridge Loan [Member]        
Cash flows from financing activities:        
Proceeds from debt 8,000      
Convertible Notes Payable [Member]        
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Amortization of debt issuance costs and discount $ 3,740 1,271 3,603 0
Cash flows from financing activities:        
Proceeds from debt   $ 10,000 $ 20,000  
Series A1 Preferred Stock and Common Stock [Member]        
Cash flows from financing activities:        
Payment for buy-back of Series A-1 Preferred Stock and Common Stock       $ (1,459)